You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics
- 2. Application of radiomics-based prediction model to predict preoperative lymph node metastasis in prostate cancer: a systematic review and meta-analysis
- 3. Sentinel lymph node biopsy omission in early-stage breast cancer: current evidence and clinical practice
- 4. Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review
- 5. Case Report: Triple-negative breast cancer with brain and meningeal metastases exhibits spatiotemporal heterogeneity in terms of HER2 expression
- 6. Radiomics models to predict axillary lymph node metastasis in breast cancer and analysis of the biological significance of radiomic features
- 7. FDA approves first twice-yearly injection that prevents HIV infection
- 8. Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
- 9. Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
- 10. Scientists find new way to predict how bowel cancer drugs will stop working – paving the way for smarter treatments
Last updated at 17:22 GMT
Hot News Makers
Health/Pharma Companies
-
120031.88
-
99599.72
-
33233.95
-
28226.80
-
23614.14
-
16651.31
-
16400.70
-
12695.57
-
10860.93
-
10831.88
Drugs, Treatments, Trials
-
12368.35
-
7340.31
-
5711.25
-
3679.41
-
2568.64
-
2503.20
-
2443.27
-
1922.50
-
1862.94
-
1161.41
Last updated at 17:10 GMT
